General Information of the Compound
| Compound ID |
CP0140575
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
[4-(2-hydroxy-2-methylpropyl)piperidin-1-yl]-(5-methoxy-1H-indol-2-yl)methanone
Show/Hide
|
||||||||||||||||||
| Synonyms |
ASP-9521
N-(indolylcarbonyl)-piperidine derivative 1
PMID28895472-Compound-15
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C19H26N2O3
|
||||||||||||||||||
| Molecular Weight |
330.428
|
||||||||||||||||||
| Canonical SMILES |
COc1ccc2[nH]c(cc2c1)C(=O)N1CCC(CC(C)(C)O)CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C19H26N2O3/c1-19(2,23)12-13-6-8-21(9-7-13)18(22)17-11-14-10-15(24-3)4-5-16(14)20-17/h4-5,10-11,13,20,23H,6-9,12H2,1-3H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
OXSCPDKUZWPWFR-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Clinical Information about the Compound
Drug 1 ( ASP-9521 )
| Drug Name | ASP-9521 | ||
|---|---|---|---|
| Company | Astellas Pharma Inc | ||
| Indication | |||
| Target(s) |
Dihydrodiol dehydrogenase type I (AKR1C3)
Modulator
|
||